Mrs Oksana Obertynska
National Pirogov Memorial Medical University, Vinnitsa (Ukraine)
The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Hypertension e-posters
Weight loss therapy in obese hypertensive patients: the effect of orlistat versus metformin
Event: ESC Congress 2021 - The Digital Experience
Topic: Obesity
Session: Risk Factors and Prevention ePosters
The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Chronic heart failure e-posters
The efficacy and safety of mineralocorticoid-receptor antagonists: spironolactone and eplerenone in resistant hypertension and chronic kidney disease stages 3
Event: ESC Congress 2019
Topic: Pharmacotherapy
Session: Hypertension treatment: drugs and devices
The relationship between plasma renin and aldosterone levels and the reduction of blood pressure with spironolactone in patients with resistant hypertension.
Event: ESC Congress 2019
Topic: Renin-Angiotensin System
Session: Secondary hypertension and genes
The renin and aldosterone levels at resistant hypertension and its connection with other clinical features
Event: ESC Congress 2018
Topic: Renin-Angiotensin System
Session: Hyperaldosteronism and hypertension: look harder!
ESC 365 is supported by
